Search by Drug Name or NDC
NDC 00338-1073-02 Dobutamine Hydrochloride in Dextrose 100 mg/100mL Details
Dobutamine Hydrochloride in Dextrose 100 mg/100mL
Dobutamine Hydrochloride in Dextrose is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is DOBUTAMINE HYDROCHLORIDE.
Product Information
| NDC | 00338-1073 |
|---|---|
| Product ID | 0338-1073_56b372ac-b2a4-4131-bc76-dc0eb036f5f2 |
| Associated GPIs | 31350015112010 |
| GCN Sequence Number | 064538 |
| GCN Sequence Number Description | dobutamine HCl in dextrose 5 % IV SOLN 250 MG/250 INTRAVEN |
| HIC3 | A1C |
| HIC3 Description | INOTROPIC DRUGS |
| GCN | 14578 |
| HICL Sequence Number | 008777 |
| HICL Sequence Number Description | DOBUTAMINE HCL IN DEXTROSE 5 % IN WATER |
| Brand/Generic | Generic |
| Proprietary Name | Dobutamine Hydrochloride in Dextrose |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dobutamine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/100mL |
| Substance Name | DOBUTAMINE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020255 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1073-02 (00338107302)
| NDC Package Code | 0338-1073-02 |
|---|---|
| Billing NDC | 00338107302 |
| Package | 18 BAG in 1 CARTON (0338-1073-02) / 250 mL in 1 BAG |
| Marketing Start Date | 1993-09-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |